C. Garthwaite, The economics of drug development: Pricing and innovation in a changing market, NBER Reporter, 2018.

A. -mullard, Synthetic lethality screens point the way to new cancer drug targets, Nat. Rev. Drug Discov, vol.16, pp.587-591, 2017.

, FDA approves longer-acting calaspargase pegol-mknl for ALL from Servier Pharmaceuticals, 2018.

T. K. Shah, S. Stockbridge, and M. , Balancing the R&D Equation: Measuring the Return from Pharmaceutical Innovation, Deloitte Centre for Health Solutions, 2016.

S. Dessain and S. Fishman, Preserving the promise. Improving the culture of biotech investment, 2017.

L. Roux, M. Guéritte, and F. , La Navelbine et le Taxotère, Histoires de sciences, ISTE Editions, Collection ''chimie moléculaire, verte, médicinale et pharmaceutique, 2017.

T. Fink and J. L. Reymond, Virtual Exploration of the Chemical Universe up to 11 Atoms of C, N, O, F: Assembly of 26.4 Million Structures (110.9 Million Stereoisomers) and Analysis for New Ring Systems, Stereochemistry, Physicochemical Properties, Compound Classes, and Drug Discovery, J.Chem.Inf. Model, vol.47, pp.342-353, 2007.

C. Copley and P. Vignal, Roche achète le français Trophos pour l'olesoxime, 2015.